Back to Top
Ebola Protection Suits, Boots & Supplies
The CDC PPE recommendation document dated 10/20/2014 mandates that people in contact or probably contact with Ebola take precautions with PPE to protect themselves. This information mandates double gloving, protective suits, booties and face protection. Face protection takes the form of N95 or better masks with face shields. All of these products can be found here at Enviro Safety. Order online now to assure yourself stock for future protection for your staff and yourself.Product recommendations are based on the CDC Ebola guidelines located here.***
Information on ebola related PPE from 3M: 3M PPE - FAQ and Product Guide.
More resources for Ebola protective equipment.
CDC Statistics on Ebola as of 7/31/2014*
Highlights
- July 23, 2014, the Guinea Ministry of Health announced a total of 427 suspect and confirmed cases of Ebola virus disease (EVD), including 319 fatal cases.
- Affected districts include Conakry, Guéckédou, Macenta, Kissidougou, Dabola, Djingaraye, Télimélé, Boffa, Kouroussa, Dubreka, Fria, and Siguiri; several are no longer active areas of EVD transmission).
- 311 cases across Guinea have been confirmed by laboratory testing to be positive for Ebola virus infection.
- In Guinea’s capital city, Conakry, 73 suspect cases have been reported to meet the clinical definition for EVD, including 37 fatal cases.
- July 23, 2014, the Ministry of Health and Sanitation of Sierra Leone and WHO reported a cumulative total of 525 suspect and confirmed cases, including 419 laboratory confirmations and 224 reported fatal cases.
- Cases have been reported from 6 Sierra Leone districts: Kailahun, Kambia, Port Loko, Kenema, Bo, and Western.
- July 23, 2014, the Ministry of Health and Social Welfare of Liberia and WHO have reported 249 suspect and confirmed EHF cases (including 84 laboratory confirmations) and 129 reported fatalities.
- Genetic analysis of the virus indicates that it is closely related (97% identical) to variants of Ebola virus (species Zaire ebola virus) identified earlier in the Democratic Republic of the Congo and Gabon (Baize, 2014
). - The Guinean Ministry of Health, the Ministry of Health and Sanitation of Sierra Leone, and the Ministry of Health and Social Welfare of Liberia are working with national and international partners to investigate and respond to the outbreak.
Controlling infection in health-care settings**
Human-to-human transmission of the Ebola virus is primarily associated with direct or indirect contact with blood and body fluids. Transmission to health-care workers has been reported when appropriate infection control measures have not been observed.
It is not always possible to identify patients with EBV early because initial symptoms may be non-specific. For this reason, it is important that health-care workers apply standard precautions consistently with all patients – regardless of their diagnosis – in all work practices at all times. These include basic hand hygiene, respiratory hygiene, the use of personal protective equipment (according to the risk of splashes or other contact with infected materials), safe injection practices and safe burial practices.
Health-care workers caring for patients with suspected or confirmed Ebola virus should apply, in addition to standard precautions, other infection control measures to avoid any exposure to the patient’s blood and body fluids and direct unprotected contact with the possibly contaminated environment. When in close contact (within 1 metre) of patients with EBV, health-care workers should wear face protection (a face shield or a medical mask and goggles), a clean, non-sterile long-sleeved gown, and gloves (sterile gloves for some procedures).
Laboratory workers are also at risk. Samples taken from suspected human and animal Ebola cases for diagnosis should be handled by trained staff and processed in suitably equipped laboratories.
*source: CDC website**source: WHO - Ebola Virus Disease Information
***3M and/or Enviro Safety (and their subsidiaries or parent companies) do not have a list of products 'recommended for Ebola,' and makes no warranties for that application. Users must follow the guidance of health authorities (such as the CDC or WHO) in conducting their own risk assessment and making their product selection.
